ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RNA Avidity Biosciences Inc

25.60
1.44 (5.96%)
Last Updated: 13:59:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 460,348
Bid Price 25.58
Ask Price 25.65
News -
Day High 26.02

Low
4.825

52 Week Range

High
27.66

Day Low 24.06
Company Name Stock Ticker Symbol Market Type
Avidity Biosciences Inc RNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.44 5.96% 25.60 13:59:06
Open Price Low Price High Price Close Price Prev Close
24.20 24.06 26.02 24.16
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,180 460,348 $ 25.15 $ 11,576,618 - 4.825 - 27.66
Last Trade Time Type Quantity Stock Price Currency
13:59:09 1 $ 25.602 USD

Avidity Biosciences (RNA) Options Flow Summary

Overall Flow

Bullish

Net Premium

23k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Avidity Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.03B 79.72M - 9.56M -212.22M -2.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avidity Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RNA Message Board. Create One! See More Posts on RNA Message Board See More Message Board Posts

Historical RNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.6926.0222.2423.42898,4251.918.06%
1 Month23.6027.6621.5624.651,040,9082.008.47%
3 Months12.3027.6611.2320.501,166,92313.30108.13%
6 Months5.3527.664.82513.381,283,27220.25378.50%
1 Year16.4027.664.82511.941,147,2589.2056.10%
3 Years21.5029.594.82515.36787,9914.1019.07%
5 Years26.5037.464.82516.42671,623-0.90-3.40%

Avidity Biosciences Description

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Your Recent History

Delayed Upgrade Clock